For example, single-cell technology can reveal that certain tumor subpopulations are more dependent on key pathways related to glucose metabolism (such as PI3K/AKT/mTOR and HIF-1α), which may provide a basis for targeted therapy. This evidence concerns the gene HIF1A and neoplasm.